WHO vaccine-preventable diseases: monitoring system. 2016 global summary

Last updated 1-December 2016 (data as of 18-November-2016)
Next overall update June 2017
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 7901 Infant (under 12 months) mortality rate: 542
GDP / capita (US$): 2'4281 Child (under 5 years) mortality rate: 832

Population data in thousands3

  2015  2014  2013  2012  2011  2000  1990  1980 
Total population 17'600  17'086  16'592  16'112  15'639  11'047  8'482  7'090 
Births 758  746  734  721  709  538  417  353 
Surviving infants 699  686  673  661  649  477  362  298 
Pop. less than 5 years 3'271  3'207  3'148  3'086  3'010  2'083  1'580  1'287 
Pop. less than 15 years 8'364  8'123  7'883  7'643  7'397  5'137  3'958  3'124 
Female 15-49 years 3'846  3'730  3'621  3'518  3'420  2'435  1'841  1'585 

Number of reported cases

(Click for retrospective incidence data for Mali)
Diphtheria
ChartChart
  143 
Japanese encephalitis
ChartChart
 
Measles
ChartChart ChartChart
  215  290  221  341  24  1'578  1'388  10'007 
Mumps
ChartChart
 
Pertussis
ChartChart
  430  2'811 
Polio*
ChartChart
  63  234 
Rubella
ChartChart
  172  19  19  19  125 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
  13  12  10  11  73  203 
Tetanus (total)**
ChartChart
  19  61  37  108  168  365  294 
Yellow fever
ChartChart
  10 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Mali)
Vaccine year result method % card seen                                                
BCG 2011  84  DHS   38  98  84  89  99*  99*  82  82 
DTP1 2011  80  DHS   38  96  85  86  99*  99*  61 
DTP3 2011  63  DHS   38  90  81  76  90  88  54  42 
DTP4         
IPV1         
HepB_BD         
HepB3 2011  63  DHS   38  90  81  76  90  88 
Hib3 2011  63  DHS   38  90  81  76  90  88 
JapEnc         
MCV1          86  72  72  85  82  55  43 
MCV2         
PCV1          90  85  86  99*  99* 
PCV3          77  79  76  87  56 
Pol3 2011  50  DHS   38  91  85  79  90  87  54  42 
Rota1          62  20 
RotaC          33  13 
RCV1         
TT2plus 2008  47  MICS   59  63  86  95  66  60  62  37 
PAB         
VAD1          81  73 
YFV 2011  28  DHS   38  84  73  75  84  81 
° indicates that more than 1 survey occurred that year.  * indicates the country reported above 100% coverage.

  Next update: Mid July 2017

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Mali)
BCG
ChartChart
  79  79  84  84  84  69  82 
DTP1
ChartChart
  80  90  85  81  80  61  67 
DTP3
ChartChart
  68  77  71  68  66  43  42 
HepB3
ChartChart
  68  77  71  68  66 
HepB_BD
ChartChart
 
Hib3
ChartChart
  68  77  71  68  66 
IPV1
ChartChart
 
MCV1
ChartChart
  76  80  80  75  72  49  43 
MCV2
ChartChart
 
PAB
ChartChart
  85  85  85  89  89  50  45 
PCV3
ChartChart
  58  78  73  68  56 
Pol3
ChartChart
  76  84  77  75  72  53  42 
RCV1
ChartChart
 
RotaC
ChartChart
  33  13 
YFV
ChartChart
  64  64  66  75  72  11 

Number of districts in the country 63  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
97 
   
/
|
|
\
Greater or equal to 90% 41
From 80 to 89% 33
From 50 to 79% 17
Less than 50% 8
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2015 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
HPV 10 years; No
IPV 14 weeks; Yes
Measles 9 months; Yes
OPV birth; 6, 10, 14 weeks; Yes
Pneumo_conj 6, 10, 14 weeks; Yes
Rotavirus 6, 10, 14 weeks; No
TT 1st contact pregnancy; +1, +6 months; +1, +1 year; Yes
Td 1st contact pregnancy; +1, +6 months; +1, +1 years; Yes
VitaminA 6 months; 1 year; Yes postpartum
YF 9 months; Yes

Immunizaton indicators

Indicator Expected answer 2015  2014  2013  2012  2011  2010  2009 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2012-2016  2012-2016  2012-2016  2012-2016  2012-2016  2007-2011  2007-2011 
Nº of districts with microplans that include activities to raise immunization coverage number 63  63  60  60    59  59 

System performance

Total Nº districts in country number 63  63  60  60  60  59  59 
Nº districts with DTP3 coverage >=80% number 47  56  46  44  43  42  48 
% of districts with DTP3 coverage >=80% From 0 to 100% 75  89  77  73  72  71  81 
Nº districts with measles (MCV1) coverage >=95% number 16  18  17  15  10  18  34 
% of districts with MCV1 coverage >=95% From 0 to 100% 25  29  28  25  17  31  58 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  No  No  Yes  Yes  No   
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  No  No  Yes  Yes  Yes  Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100% 36  17    22  45 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  No  No    No   

Sources

 1  "The 2016 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2016, data for 2015
 3  "United Nations, Population Division. The World Population Prospects - the 2015 revision". New York, 2016.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.